Key Results Among 106,088 patients, most were male ( n = 44,059, 51.3%), and the mean age was 51 (SD: 9.8) years
India Patent expires: March 2026 Adult population: 947 million Proportion of adults living with obesity a : 8% Proportion of adults living with diabetes b : 11% China Patent expires: March 2026 Adult population: 1.07 billion Proportion of adults living with obesity a : 9% Proportion of adults living with diabetes b : 12% Brazil Patent expires: March 2026 Adult population: 155 million Proportion of adults living with obesity a : 31% Proportion of adults living with diabetes b : 11% Trkiye Patent expires: 2026 Adult population: 59.0 million Proportion of adults living with obesity a : 36% Proportion of adults living with diabetes b : 16% Canada Patent expires: 2026 Adult population: 29.1 million Proportion of adults living with obesity a : 27% Proportion of adults living with diabetes b : 10% World Population: 8.23 billion More than 1 billion people in the world have a body mass index (BMI) 30 kg/m 2
However, these findings are relatively rare
The choice of treatment is personalized, taking into account your overall health, preferences, and the specific nature of your hyperthyroidism
In vivo studies have shown that microneedle-mediated delivery of semaglutide analogs leads to comparable or improved pharmacokinetics versus subcutaneous injections, with potential for once-weekly or biweekly dosing schedules [42]
Its dual mechanism may provide stronger appetite suppression and metabolic effects for certain individuals
